标题
Pharmacogenetics of P450 oxidoreductase
作者
关键词
-
出版物
Pharmacogenetics and Genomics
Volume 22, Issue 11, Pages 812-819
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2012-09-05
DOI
10.1097/fpc.0b013e328358d92b
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3
- (2012) Murali Subramanian et al. Pharmacogenetics and Genomics
- Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking
- (2012) Maria Dobrinas et al. Pharmacogenetics and Genomics
- Identification of six novel P450 oxidoreductase missense variants in Ashkenazi and Moroccan Jewish populations
- (2012) Mária Tomková et al. PHARMACOGENOMICS
- Influence of Various Polymorphic Variants of Cytochrome P450 Oxidoreductase (POR) on Drug Metabolic Activity of CYP3A4 and CYP2B6
- (2012) Xuan Chen et al. PLoS One
- Role of the interface between the FMN and FAD domains in the control of redox potential and electronic transfer of NADPH–cytochrome P450 reductase
- (2011) Louise Aigrain et al. BIOCHEMICAL JOURNAL
- Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5
- (2011) Rüdiger Kaspera et al. BIOCHEMICAL PHARMACOLOGY
- Uncovering the Role of Hydrophobic Residues in Cytochrome P450−Cytochrome P450 Reductase Interactions
- (2011) Cesar Kenaan et al. BIOCHEMISTRY
- Effects of the CYP Oxidoreductase Ala503Val Polymorphism on CYP3A Activity In Vivo: A Randomized, Open-Label, Crossover Study in Healthy Chinese Men
- (2011) Guoping Yang et al. CLINICAL THERAPEUTICS
- Advances in Human Cytochrome P450 and Personalized Medicine
- (2011) Qi Chen et al. CURRENT DRUG METABOLISM
- Identification of Cytochrome P450 Oxidoreductase Gene Variants That Are Significantly Associated with the Interindividual Variations in Warfarin Maintenance Dose
- (2011) X. Zhang et al. DRUG METABOLISM AND DISPOSITION
- Polymorphic Variants of Cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) Exhibit Altered Rates of Metabolism for Bupropion and Efavirenz: A Charge-Reversal Mutation in the K139E Variant (CYP2B6.8) Impairs Formation of a Functional Cytochrome P450-Reductase Complex
- (2011) H. Zhang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients
- (2011) Hylke de Jonge et al. PHARMACOGENOMICS
- Knockout of hepatic P450 reductase aggravates triptolide-induced toxicity
- (2011) Xiang Xue et al. TOXICOLOGY LETTERS
- Personalized vascular medicine: Individualizing drug therapy
- (2011) Emil M deGoma et al. VASCULAR MEDICINE
- Genetic Polymorphisms and Haplotypes of POR, Encoding Cytochrome P450 Oxidoreductase, in a Japanese Population
- (2010) Yoshiro Saito et al. Drug Metabolism and Pharmacokinetics
- Consequences of POR mutations and polymorphisms
- (2010) Walter L. Miller et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19
- (2010) Vishal Agrawal et al. Pharmacogenetics and Genomics
- Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro
- (2010) Duanpen Sandee et al. Pharmacogenetics and Genomics
- Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase
- (2010) Vishal Agrawal et al. Pharmacogenetics and Genomics
- CYP3A5-mediated metabolism of midazolam in recombinant systems is highly sensitive to NADPH-cytochrome P450 reductase activity
- (2010) Hege Christensen et al. XENOBIOTICA
- Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
- (2009) Shu-Feng Zhou et al. DRUG METABOLISM REVIEWS
- Polymorphism of human cytochrome P450 enzymes and its clinical impact
- (2009) Shu-Feng Zhou et al. DRUG METABOLISM REVIEWS
- Nomenclature for alleles of the cytochrome P450 oxidoreductase gene
- (2009) Sarah C. Sim et al. Pharmacogenetics and Genomics
- The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test
- (2009) Beatrice Oneda et al. Pharmacogenetics and Genomics
- Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation
- (2009) Ana M Gomes et al. PHARMACOGENOMICS
- Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
- (2008) Shu-Feng Zhou CURRENT DRUG METABOLISM
- P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity
- (2008) Steven N Hart et al. Expert Opinion on Drug Metabolism & Toxicology
- Genetic variation in human P450 oxidoreductase
- (2008) Walter L. Miller et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism
- (2008) Steven N. Hart et al. Pharmacogenetics and Genomics
- Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations
- (2008) N. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started